Search

Stryker Corp

Fechado

SetorSaúde

335.79 -1.55

Visão Geral

Variação de preço das ações

24h

Atual

Mín

330.85

Máximo

339.68

Indicadores-chave

By Trading Economics

Rendimento

-104M

745M

Vendas

-1.2B

6B

P/E

Médio do Setor

38.93

64.641

EPS

2.6

Rendimento de Dividendos

1.04

Margem de lucro

12.375

Funcionários

56,000

EBITDA

-416M

1.3B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+12.62% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

1.04%

2.31%

Próximos Ganhos

29 de out. de 2026

Próxima data de dividendos

30 de out. de 2026

Próxima data de ex-dividendo

29 de set. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.1B

129B

Abertura anterior

337.34

Fecho anterior

335.79

Sentimento de Notícias

By Acuity

67%

33%

291 / 340 Ranking em Healthcare

Stryker Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31 de jul. de 2026, 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30 de jul. de 2026, 23:41 UTC

Social Media
News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29 de jul. de 2026, 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28 de jul. de 2026, 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27 de jul. de 2026, 19:06 UTC

Social Media
News
Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24 de jul. de 2026, 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22 de jul. de 2026, 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21 de jul. de 2026, 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20 de jul. de 2026, 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Comparação entre Pares

Variação de preço

Stryker Corp Previsão

Preço-alvo

By TipRanks

12.62% parte superior

Previsão para 12 meses

Média 384.25 USD  12.62%

Máximo 455 USD

Mínimo 340 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Stryker Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

18 ratings

16

Comprar

2

Manter

0

Vender

Sentimento

By Acuity

291 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat